Health Care: Drugs

Galena Biopharma Inc (GALE: NASDAQ)

$2.6 n/a | n/a%
12/08/16 - 04:00 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 0.00 0.00 0.00 0.00
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 0.00 0.00 0.00 0.00
Selling, General, and Administrative Expenses 10.61M 16.23M 8.06M 6.58M
Research & Development 23.61M 27.67M 20.42M 14.61M
Operating Income before D & A (EBITDA) -34.22M -43.90M -28.49M -21.20M
Depreciation & Amortization 355.00K 362.00K 286.00K 49.00K
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net -3.61M 16.73M -40.98M -13.14M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -38.19M -27.54M -69.75M -34.39M
Interest Expense 760.00K 1.11M 807.00K 33.00K
Pre-Tax Income -38.95M -28.65M -70.56M -34.43M
Income Taxes 365.00K 0.00 1.05M -1.05M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -38.96M -28.28M -71.33M -33.33M
Net Income From Discontinued Operations -24.95M -8.32M -5.35M -1.64M
Net Income From Total Operations -63.90M -36.61M -76.68M -34.97M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -63.90M -36.61M -76.68M -34.97M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-38.96M -28.28M -71.33M -33.33M
Preferred Dividends
Net Income Available To Common -38.96M -28.28M -71.33M -33.33M
Basic EPS from Continuing Ops. -5.00 -4.80 -15.80 -10.60
Basic EPS from Discontinued Ops. -3.20 -1.40 -1.20 -0.60
Basic EPS from Total Operations -8.20 -6.20 -17.00 -11.20
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -8.20 -6.20 -17.00 -11.20
Basic Normalized Net Income/Share -5.00 -4.80 -15.80 -10.60
EPS fr Continuing Ops. -5.00 -4.80 -15.80 -10.60
EPS fr Discontinued Ops -3.20 -1.40 -1.20 -0.60
EPS fr Total Ops. -8.20 -6.20 -17.00 -11.20
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -8.20 -6.20 -17.00 -11.20
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-5.00 -4.80 -15.80 -10.60
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with GALE

Latest GALE Headlines from TheStreet

More Financial News for GALE

Press Releases for GALE

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter